NASDAQ: CHARCharlton Aria Acquisition Corp Stock
$10.78+0.03 (+0.28%)
Updated Jun 12, 2026
CHAR Price
$10.78
Fair Value Price
N/A
Market Cap
$115.04M
52 Week Low
$10.26
52 Week High
$11.30
P/E
39.93x
P/B
-61.02x
P/S
N/A
PEG
3.9x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.98M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$543k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CHAR Overview
Charlton Aria Acquisition Corporation currently conducts no substantive business operations. Its primary objective is to execute a business combination, which may take the form of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar arrangements, with one or multiple businesses or entities. Established in 2024, this Delaware-based company, located in Wilmington, was formerly a subsidiary of ST Sponsor II Limited.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CHAR's potential to beat the market
- CHAR doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
CHAR
RankedUnranked of 34
RankedUnranked of 34
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $24.43 | C | |
| $10.09 | C |
Be the first to know about important CHAR news, forecast changes, insider trades & much more!
CHAR News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CHAR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CHAR ($10.78) is trading above its intrinsic value of $2.38, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CHAR is poor value based on its earnings relative to its share price (39.93x), compared to the US market average (14.15x)
P/E vs Market Valuation
CHAR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CHAR due diligence checks available for Premium users.
Valuation
CHAR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
39.93x
Industry
15.77x
Market
14.15x
CHAR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CHAR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CHAR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-61.02x
Industry
77.39x
CHAR price to earnings growth (PEG)
For valuing profitable companies with growth potential
CHAR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CHAR's financial health
Profit margin
Revenue
$0.0
Net Income
$665.8k
Profit Margin
0%
CHAR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$89.5M
Liabilities
$1.9M
Debt to equity
-1.01
CHAR's short-term liabilities ($198.51k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CHAR's long-term liabilities ($1.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CHAR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CHAR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$106.5k
Investing
$0.0
Financing
$0.0
CHAR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CHAR vs Shell Company Stocks
Charlton Aria Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.